Synonyms nAChRα3&β4, α3β4 receptor |
Introduction- |
Target |
Mechanism α3β4 receptor antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism Monoamine reuptake inhibitor [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism α3β4 receptor antagonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Aug 2024 |
Sponsor / Collaborator- |
Start Date01 May 2021 |
Sponsor / Collaborator |
Start Date14 Apr 2020 |
Sponsor / Collaborator |